跳至主要内容
临床试验/ACTRN12609000270213
ACTRN12609000270213尚未招募4 期

An open trial of a Cognitive Behavioural Therapy (CBT)-based smoking cessation plus Varenicline intervention in people with a psychotic disorder

Pfizer Australia (Investigator Initiated Grant)0 个研究点目标入组 15 人开始时间: 2009年5月15日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Aged 18 years and over; Diagnosis of a psychotic disorder (e.g. schizophrenia, schizoaffective disorder, bipolar disorder, etc.) and on stable psychiatric medication for at least three months; Current heavy smoker (at least 15 cigarettes per day).

排除标准

  • (1) Non-psychotic illness; (2) People who are smoking fewer than 15 cigarettes per day; (3) Non-English speakers; (4) People with organic brain diseases; (4) An unstable psychiatric (eg., actively suicidal) or medical condition (eg., uncontrolled diabetes); (5) People with any specific contraindication to the use of varenicline; (6) Pregnant women.

研究者

发起方
Pfizer Australia (Investigator Initiated Grant)

相似试验